MedTrace Logo

BIIR Gene to Manage Heart Allograft Patients

NCT01929785 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2016-01-13

No results posted yet for this study

Summary

This is a single center observational study. Duration of the study is 1 year. Participants will be followed in 2 groups. Group 1 will include all patients who have undergone a heart transplant, through the first year post transplant. Group 2 will include heart transplant recipients from 1 year to 2 years post transplant. Groups will be enrolled simultaneously. It is anticipated each group will have 25 participants.

Conditions

  • Cardiac Transplant Failure

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Shelley Hall, MD · Baylor Health Care System

Eligibility

Min Age
18 Years
Max Age
73 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01929785 on ClinicalTrials.gov